Photo of Michelle Yeary

Depending on your age, today’s title may evoke images of Hayley Mills or Lindsay Lohan.  We won’t ask you which.  It can be your secret.  But in an industry where remakes are rarely worth the price of admission, the Parent Trap is a rare exception, and we won’t fault you for liking both.  Today’s parent

Plaintiffs in mass tort drug and device litigation do not like to focus on the individual cases.  They like to amass the individual cases.  They like to file the individual cases.  But as we see all too often those filings tend to be indiscriminate and without the benefit of proper early vetting.  That is what

We offer today’s case as a good recitation of Alabama warranty and fraud law.  Both have precise pleading requirements that plaintiff failed to meet in Morris v. Angiodynamics, Inc., 2024WL 476884 (M.D. Ala. Feb. 7, 2024). 

Plaintiff was implanted with a port used to deliver his chemotherapy treatments.  About five months after implant, plaintiff

Today’s post is a short cautionary tale about Federal Rule of Civil Procedure 15(a)(1) and plaintiff’s “one free shot” at amending a complaint.  That rule provides:

(B) if the pleading is one to

On February 6, Dechert is proud to host the 2024 Life Sciences Day, an interdisciplinary program designed for in-house counsel, chief officers, and strategic investors. This dynamic half-day event will feature expert panels discussing key issues in the life sciences sector and include speakers from leading pharmaceutical and biotech companies.  

Our panelists will